Chronic Low Back Pain Clinical Trial
— MedExTOfficial title:
Combined Meditation and Exercise as a Treatment for Patients With Chronic Back Pain
Verified date | April 2021 |
Source | Duquesne University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study evaluates the analgesic effect of a combination treatment of exercise and mindfulness based meditation in patients with chronic back pain. Half of the participants will partake in a 4-week exercise and meditation intervention, while the other half will receive a placebo treatment. The investigators hypothesize that a combination treatment reduces disability and pain more than the control intervention.
Status | Completed |
Enrollment | 42 |
Est. completion date | June 30, 2019 |
Est. primary completion date | March 31, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 60 Years |
Eligibility | Inclusion Criteria: 1. Presence of clinically diagnosed nonspecific low back pain for at least 6 months 2. Body mass index within the normal to overweight range (18.5-29.9) 3. Resting heart rate 60 to 100 beats per minute 4. Resting blood pressure less than or equal to 140/90 5. Able to independently ambulate community distances without external support (e.g., walker, cane) Exclusion Criteria: 6. Age less than 18 or greater than 60 years 7. BMI = 30 or = 18.4 8. Cardiovascular or respiratory disease 9. Neurological disease, unrelated to low back pain 10. Radicular low back pain 11. Back pain associated with neuropathy 12. Diabetes mellitus, Types 1 and 2 13. Diagnosed with a chronic pain condition, unrelated to low back pain 14. Acute pain 15. Regular participation in high intensity athletic/sporting activities 16. Sedentary lifestyle 17. Currently pregnant 18. Current cigarette smoker 19. On-going litigation associated with back pain 20. Inability to walk independently without external support (e.g. walker). 21. Regular participation in meditation techniques or training in Mindfulness-based stress reduction |
Country | Name | City | State |
---|---|---|---|
United States | Duquesne University | Pittsburgh | Pennsylvania |
Lead Sponsor | Collaborator |
---|---|
Duquesne University | University of Pittsburgh |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in Roland Morris Disability Questionnaire | The Roland-Morris Disability Questionnaire is designed to assess self-rated physical disability caused by low back pain. The patient is asked to tick a statement when it applies to him that specific day, this makes it possible to follow changes in time. The end score is the sum of the ticked boxes. The score ranges from 0 (no disability) to 24 (max. disability). | baseline and 4 weeks | |
Secondary | Change in Cutaneous Sensation | Subjects will be examined using cutaneous sensory filaments on the forearm with data recorded in grams. | baseline and 4 weeks | |
Secondary | Fear Avoidance Beliefs Questionnaire | The Fear-Avoidance Beliefs Questionnaire (FABQ) is a questionnaire based on the Fear-Avoidance Model of Exaggerated Pain Perception, a model created in attempts to explain why some patients with acute painful conditions can recover while other patients develop chronic pain from such conditions. The FABQ measures patients' fear of pain and consequent avoidance of physical activity because of their fear. This questionnaire consists of 16 items, with each item scored from 0-6. Higher scores on the FABQ are indicative of greater fear and avoidance beliefs | baseline and 4 weeks | |
Secondary | Freiburg Mindfulness Inventory | The FMI is a 14-item questionnaire for measuring mindfulness. It is most suitable in generalized contexts, where knowledge of the Buddhist background of mindfulness cannot be expected. The 14 items cover all aspects of mindfulness. The purpose is to characterize the experience of mindfulness. The subject is asked to answer every statement as honestly and spontaneously as possible. Each statement is scored on a 1 to 4 scale and a composite score is calculated from all statements. | baseline and 4 weeks | |
Secondary | VAS back pain (intensity & unpleasantness) | Participants will be asked to rate their current level of back pain intensity on a Visual Analog Scale (VAS) ranging from 0 to 10 | baseline, daily (pre and post intervention), and 4 weeks | |
Secondary | State-Trait Anxiety Inventory (STAI) | The STAI is an introspective psychological inventory consisting of 40 self-report items pertaining to anxiety affect. It distinguishes between a person's state and trait anxiety levels. The A-Trait and A-State scales comprise 20 items each, scored on a 4-point Likert-type response scale. Higher STAI scores suggest higher levels of anxiety. | baseline and 4 weeks | |
Secondary | Change in Pressure Sensation | Subjects will be examined using a pressure algometer to determine a pressure pain threshold, measured in Newtons | baseline and 4 weeks | |
Secondary | Change in Heat unpleasantness | Subjects will be examined using a heat block with a determined temperature threshold. Subjects will report unpleasantness using a VAS scale. | baseline and 4 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03243084 -
Transcranial Alternating Current Stimulation in Back Pain- Pilot Sudy
|
N/A | |
Suspended |
NCT04735185 -
Stem Cells vs. Steroids for Discogenic Back Pain
|
N/A | |
Completed |
NCT03162952 -
RAND Center of Excellence for the Study of Appropriateness of Care in CAM
|
||
Completed |
NCT03240146 -
Pulsed Shortwave Therapy Treatment for Chronic Musculoskeletal Low Back Pain
|
N/A | |
Completed |
NCT05282589 -
Lumbopelvic Manipulation Effects on Fatigue in Chronic Low Back Pain Patients
|
N/A | |
Completed |
NCT03637998 -
Physical Activity on Neurophysiologic Gene Expression Profiles of Chronic Low Back Pain
|
N/A | |
Recruiting |
NCT02289170 -
Clinical Study to Evaluate the Safety and Efficacy of Heating and Cooling Combination Therapeutic Device(OCH-S100)
|
N/A | |
Active, not recruiting |
NCT01944163 -
The IMPACT of a Referral Model for Axial Spondyloarthritis in Young Patients With Chronic Low Back Pain
|
N/A | |
Completed |
NCT02231554 -
Feldenkrais vs Back School for Treating Chronic Low Back Pain: a Randomized Controlled Trial
|
N/A | |
Recruiting |
NCT02063503 -
Identification of Prognostic Indicators for Rehabilitation in Chronic Nonspecific Low Back Pain Patients
|
N/A | |
Terminated |
NCT01620775 -
MR(Magnetic Resonance) Imaging of Neurotransmitters in Chronic Pain
|
N/A | |
Completed |
NCT01704677 -
Lumbar Disc Prosthesis Versus Multidisciplinary Rehabilitation; 8-year Follow-up
|
N/A | |
Completed |
NCT01177280 -
Prevalence of Potential Cytochrome P450 Pharmacokinetic Incident Drug-Drug Interactions Among Chronic Low Back Pain Patients Taking Opioid Analgesics and Associated Economic Outcomes
|
N/A | |
Completed |
NCT01177241 -
Cytochrome P450 Pharmacokinetic DDIs Among Patients With Chronic Low Back Pain Taking Opioids
|
N/A | |
Completed |
NCT01177254 -
Exposure to Potential Cytochrome P450 Pharmacokinetic Drug-Drug Interactions Among Osteoarthritis Patients: Incremental Risk of Multiple Prescriptions
|
N/A | |
Completed |
NCT01490905 -
A Double Blind Placebo Study to Determine the Effectiveness of Theramine on the Management of Chronic Back Pain
|
Phase 4 | |
Completed |
NCT00984815 -
Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug Treatment
|
Phase 3 | |
Completed |
NCT00767806 -
A Study for Patient With Chronic Low Back Pain
|
Phase 3 | |
Completed |
NCT00761150 -
Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)
|
Phase 3 | |
Completed |
NCT00763321 -
Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)
|
Phase 3 |